2703 篇
1106 篇
195320 篇
3430 篇
6334 篇
2259 篇
2858 篇
543 篇
29930 篇
10379 篇
3229 篇
776 篇
2320 篇
1331 篇
452 篇
753 篇
1393 篇
2663 篇
2752 篇
4123 篇
全球视网膜药物市场报告(2025-2029年)
Global Retinal Drugs Market 2025-2029
Retinal drugs are the medications that are used in the treatment of retinal diseases. Anti-vascular endothelial growth factor (VEGF) agents and corticosteroids are the two major drug classes that are being used for the treatment of various retinal diseases such as wet age-related Macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy, and myopic choroidal neovascularization (mCNV). Among them, anti-VEGF agents are considered the gold standard for the treatment of various retinal diseases such as AMD, DME, and RVO.